may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.�
.